acquired
Stage
About
Gemin X was a Canadian biotechnology company focused on developing oncology therapeutics. It was acquired by Cephalon for $225 million in 2003.
Explore Gemin X's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.